Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology.

Area of Science:

• Genomics and transcriptomics
• High-throughput sequencing technologies
• Gene expression analysis

Background:

• RNA-sequencing (RNA-seq) offers a high-throughput alternative to microarray technologies, necessitating comparative performance evaluations.
• Previous cross-platform comparisons were limited in scope and often focused solely on gene annotation.
• A comprehensive assessment is required to understand the nuances of RNA-seq and microarray performance.

Purpose of the Study:

• To conduct an extensive and precise comparative assessment of RNA-seq and microarray platforms.
• To elucidate differences and similarities in dynamic range, signal fidelity, fold-change accuracy, and qRT-PCR concordance.
• To introduce and validate the 'transcript pattern' concept for robust multi-platform comparisons.

Main Methods:

• Evaluation of six different gene expression platforms, including RNA-seq and microarray technologies.
• Analysis of data at three levels: entire datasets, common RefSeq genes, and transcript pattern-defined subsets.
• Assessment of dynamic range, signal fidelity, fold-change with sample titration, and concordance with quantitative reverse transcription PCR (qRT-PCR) using TaqMan assays.

Main Results:

• Substantial core similarities were observed across all six platforms.
• Two RNA-seq protocols generally outperformed three of four microarray platforms in most assessed categories.
• A modified Agilent microarray protocol demonstrated comparable or superior performance to RNA-seq, particularly in fold-change evaluation, with over 80% concordance with qRT-PCR.

Conclusions:

• Microarray technology can achieve performance comparable to RNA-seq in key features, contingent on similar dynamic ranges.
• The introduced 'transcript pattern' method offers a strategy to mitigate confounding factors in multi-platform comparisons.
• This study provides valuable insights for selecting appropriate gene expression profiling technologies.